Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lunan Better Pharmaceutical Co., Ltd., a core subsidiary of the Lunan Pharmaceutical Group, is a major pharmaceutical manufacturer based in Linyi, Shandong Province, China. Established in 2003, the company specializes in the development and production of a broad range of western medicines, including formulations for cardiovascular, digestive, respiratory, and nervous system conditions. Its flagship products, notably Lunan Xinkang (Isosorbide Mononitrate) and Lunan Likang (Omeprazole), are widely recognized in the Chinese domestic market for their efficacy and quality. The company operates high-standard manufacturing facilities that are fully GMP-certified and has been designated as a National High-tech Enterprise. Lunan Better leverages the extensive R&D and distribution capabilities of its parent group to maintain a competitive presence in the Chinese pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lunan Better Pharmaceutical.